Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]University of Michigan Rogel Cancer Center"
Count: 293
Selected: 0
NCT04458168Feasibility and Evaluation of a Self-care App to Enhance Purposeful Living
NCT03570619Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations
NCT03639935Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy
NCT04431635Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma
NCT02400190The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
NCT01288534Hypofractionated Stereotactic Body Radiation Therapy (SBRT)
NCT02059213A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer
NCT00843375Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
NCT06047626Living Well With Lymphoma
NCT04530526Surgical Treatment of Post-surgical Mastectomy Pain Utilizing the Regenerative Peripheral Nerve Interface
NCT05162846Methods for Increasing Genetic Testing Uptake in Michigan
NCT04848337Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer
NCT05956041Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
NCT05764005Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
NCT04925089Localized Leiomyosarcoma Biomarker Protocol
NCT05552664The Genetic Information and Family Testing (GIFT) Study
NCT04477200Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
NCT04858256Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
NCT02783950Genomics in Michigan Impacting Observation or Radiation
NCT04754399Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias
NCT03416153Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
NCT00593866Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer
NCT05653388Metastatic Leiomyosarcoma Biomarker Protocol
NCT05866302Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
NCT05583422Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics-related AEs While Receiving Fluoropyrimidine or Irinotecan Therapy
NCT04268134Altering Lipids for Tolerance of Aromatase Inhibitor Therapy
NCT04748042Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
NCT04396808Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
NCT06046014Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer Survivors
NCT05691400Phase IV Multi-arm Study of CDK4/6 Pharmacokinetics in Healthy Volunteers With Known CYP3A4*22 Genotype
NCT03562507Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell Carcinoma
NCT04194554A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer
NCT04827446Lighting Intervention for Cancer-related Fatigue
NCT05169957Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)
NCT05140252Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid
NCT04503668Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients
NCT01210027A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion
NCT05945121Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
NCT01975597Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer
NCT05911269Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors
NCT05867667Cardiac Rehabilitation to Improve Breast Cancer Outcomes
NCT05578898CLEAR Care Companion Application
NCT04845035Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
NCT04703920Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer
NCT04510311Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors
NCT04497038Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy
NCT04076579Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma
NCT03242915Pembrolizumab in Combination With Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients With Targetable Genetic Alterations, Previously Treated With Appropriate Targeted Agents, With Progressive Disease
NCT03240016Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer
NCT03099356Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer